On May 6, 2024, Greenwave Technology Solutions, Inc. closed the transaction. The company received $112,499,985 in funding pursuant to exemption provided under Regulation D. The transaction included participation from 19 investors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | -4.37% | -4.37% | +12.42% |
May. 23 | Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing | MT |
May. 10 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.42% | 327M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Zura Bio Limited announced that it has received $112.4935 million in funding from a group of investors